Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Diagnostic or test agent produces in vivo fluorescence
Reexamination Certificate
2011-03-01
2011-03-01
Jones, D L (Department: 1618)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Diagnostic or test agent produces in vivo fluorescence
C424S001110, C424S001650, C424S001690, C424S009100
Reexamination Certificate
active
07897142
ABSTRACT:
The invention relates to new peptide-based compounds and their use in diagnostic optical imaging techniques. More specifically the invention relates to the use of such peptide-based compounds as targeting vectors that bind to receptors associated with angiogenesis. The compounds are labelled with at least one cyanine dye reporter and may be used as contrast agents in optical imaging in diagnosis of angiogenesis-related diseases.
REFERENCES:
patent: 7351790 (2008-04-01), Cuthbertson et al.
patent: 7521419 (2009-04-01), Cuthbertson et al.
patent: 7608243 (2009-10-01), Cuthbertson et al.
patent: 01/77145 (2001-10-01), None
patent: 03/006491 (2003-01-01), None
patent: 2005/003166 (2005-01-01), None
PCT/NO2005/000210 International Search Report and Written Opinion dated Oct. 12, 2005.
Chen, X, et.al., “In vivo near-infrared fluorescence imaging of integrin .alpha.v.beta.3 in braintumor xenografts” Cancer Research vol. 64, No. 21, Nov. 1, 2004 pp. 8009-8014.
Achilefu, S, et.al. “Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression” Proceedings of the National Academy of science, USA, vol. 102, No. 22, May 31, 2005 pp. 7976-7981.
Cuthbertson Alan
Nairne Robert James
GE Healthcare AS
Jones D L
LandOfFree
Peptide based-compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide based-compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide based-compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2621582